KCAS-webinar-thumb_2024-010_receptor occupancy assay Webinars
View webinar KCAS Bio Webinar: Development and Validation of Receptor Occupancy (RO) Assays: Challenges and Approaches

Webinar Description: Acquire a deeper understanding of Receptor Occupancy (RO) assays as measured by flow cytometry.  We will discuss the fundamental considerations for RO method design, development, and validation.  Within each of these areas, Dr. Evans highlights critical areas of consideration which can impact your ability to robustly quantify Receptor Occupancy within…

KCAS-webinar-thumb_2024-09_Spectral Unmixing Webinar Webinars
View webinar KCAS Bio Webinar: Spectral Unmixing Impact Comparison Across Immunophenotyping Panels and Matrices

Webinar Description: KCAS Bio will present results from a recent validation of two IP panels on the Cytek Aurora in PBMCs. We have analyzed the impact of different fixation buffers on the efficacy of reference controls over time, and we will explore how to help improve workflow standards and process…

KCAS-blog-thumb_2024-010_Biomarker-Assay-Development2 Webinars
View webinar KCAS Bio Webinar- Biomarker Assay Development: Qualification Vs Validation Debate

Webinar Description: Biomarkers are a critical aspect of bioanalytical testing, as they provide a vast amount of information, from the effects of a drug on the subject to determining the drug’s mechanism of action and the correct dose for a patient. When developing a biomarker, it is important to understand…

KCAS-webinar-thumb_2024-09_Hybrid LC-MS_MS Webinars
View webinar Hybrid LC-MS/MS Technology Becoming the New Norm in the Bioanalysis of Antibody-Drug Conjugates

As the pharmaceutical industry continues to evolve, so does the technology behind drug development. One of the most groundbreaking advancements in bioanalysis is Hybrid LC-MS/MS technology, which is rapidly becoming the new standard for analyzing Antibody Drug Conjugates (ADCs). KCAS Bio is proud to be at the forefront of this…

KCAS-blog-webinar_2024-08_ Anti-Drug Antibodies Testing Webinars
View webinar KCAS Bio’s Webinar on Anti-Drug Antibodies Testing

In the dynamic field of biotherapeutics, understanding and managing anti-drug antibodies (ADAs) is critical for the success of drug development programs. ADAs can potentially neutralize the efficacy of biotherapeutic drugs, making it essential to have robust testing methodologies in place from the preclinical to clinical stages. KCAS Bio is excited…

KCAS-blog-webinar_2024-08_ considerations for conventional and spectral flow Webinars
View webinar Evolving Best Practices: Considerations for Conventional and Spectral Flow

In the fast-paced world of drug development, the ability to produce accurate and reproducible data is paramount. That’s why staying updated with the latest best practices in flow cytometry is crucial. Our webinar, “Evolving Best Practices: Considerations for Conventional and Spectral Flow,” dives deep into the rapidly advancing field of…

KCAS-blog-webinar_2024-08_high-complexity flow cytometry Webinars
View webinar Panel Discussion: Evolving Best Practices in High-Complexity Flow Cytometry

In the rapidly advancing world of flow cytometry, staying ahead of the curve is essential for driving impactful research and drug development. Our panel discussion, “Evolving Best Practices in High-Complexity Flow Cytometry,” sheds light on the latest developments that can enhance and accelerate your research efforts. Flow cytometry has long…

KCAS-blog-thumb_2024-Panel Webinars
View webinar Panel Discussion Exploring Advanced Biopharmaceutical Quantification Techniques

For researchers and professionals working in the biopharmaceutical industry, an upcoming Bioanalysis Zone Panel Discussion will offer a unique opportunity to stay informed about the latest advancements in quantitative analysis techniques. Research projects can only succeed when selecting the appropriate biopharmaceutical quantification technique. Staying up-to-date on…

PATTERN_BLUE_1320x780_2 Webinars
View webinar KCAS Bio Webinar – Produced by Bioanalysis Zone “Bioanalytical Considerations for Immunogenicity of Cell and Gene Therapies”

Produced by Bioanalysis Zone Recorded on December 11, 2023 Webinar available here.  Webinar Description: In this webinar, Dominic Warrino discusses the bioanalytical considerations of immunogenicity of cell and gene therapies. Bioanalysis method development and method validation of immunogenicity assays for support of cell and…

PATTERN_ORANGE_1320x780 Webinars
View webinar KCAS Bio Webinar “Navigating the Complex Landscape of Lipid Panels & Small Molecule Biomarkers in Drug Discovery”

Produced by AAPS Organized by Sciex Recorded on December 6, 2023 eChalkTalk available here.  Webinar Description: In this webinar, scientists from KCAS Bio, along with specialists from SCIEX Biopharma & Pharma Solutions discuss • Developing robust assays for PD biomarkers and their challenges…

KCAS-blog-thumb_2022_Webinar-CGT-June-2022-1 Webinars
View webinar Upcoming KCAS Webinar (June 24th): “The Age of Cell and Gene Therapies is Upon Us – So What Does That Mean for Bioanalysis?”

Being produced by Xtalks on Friday, June 24, 2022 | 12pm EDT (NA) / 5pm BST (UK) / 6pm CEST (EU-Central) 60 min Webinar Description: Cell and gene therapies (CGTs) are types of treatment that use cellular or genetic material with the goal of treating a disease or a…

KCAS-blog-thumb_2022_Webinar-Hybrid-Gold-Standard-1 Webinars
View webinar KCAS Webinar: “Is Hybrid LC-MS/MS becoming the new Gold Standard?”

Originally produced by Xtalks on Friday, April 22, 2022 | 12pm EDT (NA) / 5pm BST (UK) / 6pm CEST (EU-Central)  60 min Webinar Description: Due to the relative maturity of the technology, most people’s instinct when thinking about bioanalysis of large molecules is towards ligand binding assays.